HomeXENE • NASDAQ
add
Xenon Pharmaceuticals Inc
Previous close
$37.22
Day range
$36.19 - $37.22
Year range
$26.74 - $46.00
Market cap
2.79B USD
Avg Volume
874.42K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 19.24M | -0.81% |
Net income | -84.71M | -46.24% |
Net profit margin | — | — |
Earnings per share | -1.07 | -42.67% |
EBITDA | -93.60M | -36.71% |
Effective tax rate | 0.73% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 487.54M | -32.43% |
Total assets | 674.28M | -23.72% |
Total liabilities | 40.30M | 0.85% |
Total equity | 633.98M | — |
Shares outstanding | 77.11M | — |
Price to book | 4.52 | — |
Return on assets | -33.24% | — |
Return on capital | -34.76% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -84.71M | -46.24% |
Cash from operations | -64.23M | -106.19% |
Cash from investing | 82.26M | -24.66% |
Cash from financing | 65.00K | — |
Net change in cash | 18.72M | -75.94% |
Free cash flow | -54.28M | -59.71% |
About
Founded
1996
Headquarters
Website
Employees
322
